FindTrial
Sign In

K-115 clinical pharmacology study

K-115 clinical pharmacology study

Status
Unknown
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-jRCT2080222654
Enrollment
6
Registered
2014-11-14
Start date
2014-11-14
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy volunteers

Interventions

investigational material(s) Generic name etc : K-115 INN of investigational material : Therapeutic category code : 131 Agents for ophthalmic use Dosage and Administration for Investigational material

Sponsors

Kowa Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Japanese healthy adult 2. Aged 20 to 64 years

Exclusion criteria

Exclusion criteria: (1)Subject who is observed ophthalmic (except for non-severe myopia, hyperopia, astigma and visus senilis) or systemic disease or disorder in the examination at the initiation of observation period (2)Subject who is taken eye surgery or laser eye surgery on one eye by the initiation of observation period (3)Subject who is taken ophthalmic treatment on one eye by the initiation of observation period etc

Design outcomes

Primary

MeasureTime frame
Safety:Adverse event (AE) and adverse drug reaction (ADR) Safety:AE and ADR—

Secondary

MeasureTime frame
N/A N/A—

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026